Franchimont D - Search Results

1

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases.

De Jager PL, Franchimont D, Waliszewska A, Bitton A, Cohen A, Langelier D, Belaiche J, Vermeire S, Farwell L, Goris A, Libioulle C, Jani N, Dassopoulos T, Bromfield GP, Dubois B, Cho JH, Brant SR, Duerr RH, Yang H, Rotter JI, Silverberg MS, Steinhart AH, Daly MJ, Podolsky DK, Louis E, Hafler DA, Rioux JD; Quebec IBD Genetics Consortium; NIDDK IBD Genetics Consortium. De Jager PL, et al. Among authors: franchimont d. Genes Immun. 2007 Jul;8(5):387-97. doi: 10.1038/sj.gene.6364398. Epub 2007 May 31. Genes Immun. 2007. PMID: 17538633 Free article.

2

[Genetics of inflammatory bowel disease].

Franchimont D, Louis E. Franchimont D, et al. Bull Mem Acad R Med Belg. 2010;165(10-12):435-49; discussion 450-2. Bull Mem Acad R Med Belg. 2010. PMID: 22288101 French.

3

Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.

Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, Boniver J, Belaiche J, Malaise M. Louis E, et al. Among authors: franchimont d. Clin Exp Immunol. 2000 May;120(2):241-6. doi: 10.1046/j.1365-2249.2000.01227.x. Clin Exp Immunol. 2000. PMID: 10792371 Free PMC article.

4

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.

Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Devière J, Rutgeerts P. Franchimont D, et al. Gut. 2004 Jul;53(7):987-92. doi: 10.1136/gut.2003.030205. Gut. 2004. PMID: 15194649 Free PMC article.

5

[Current contribution of genetics in intestinal inflammatory diseases].

Louis E, Belaiche J, Franchimont D, Delwaide J, Gast P. Louis E, et al. Among authors: franchimont d. Acta Clin Belg. 1993;48(6):383-91. doi: 10.1080/17843286.1993.11718334. Acta Clin Belg. 1993. PMID: 8128817 French.

6

Intestinal permeability in Crohn's disease.

Franchimont D, Louis E, Simon S, Belaiche J. Franchimont D, et al. Acta Gastroenterol Belg. 1996 Jan-Mar;59(1):15-9. Acta Gastroenterol Belg. 1996. PMID: 8686412 Review.

7

[Corticosteroid sensitivity, dependence and resistance in inflammatory and immunologic diseases. Physiopathologic review].

Franchimont D, Belaiche J, Geenen V. Franchimont D, et al. Rev Med Liege. 1998 Jan;53(1):33-7. Rev Med Liege. 1998. PMID: 9555181 Review. French.

8

Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?

Louis E, Peeters M, Franchimont D, Seidel L, Fontaine F, Demolin G, Croes F, Dupont P, Davin L, Omri S, Rutgeerts P, Belaiche J. Louis E, et al. Among authors: franchimont d. Clin Exp Immunol. 2000 Jan;119(1):64-8. doi: 10.1046/j.1365-2249.2000.01106.x. Clin Exp Immunol. 2000. PMID: 10606965 Free PMC article.

9

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

Franchimont D, Ferrante M, Louis E, De Vos M, Dewit O, Van Hootegem P, Moreels T, Liefferinckx C, Bossuyt P, Baert F, Rahier JF, Vermeire S. Franchimont D, et al. Acta Gastroenterol Belg. 2018 Jan-Mar;81(1):49-53. Acta Gastroenterol Belg. 2018. PMID: 29562378 Free article. No abstract available.

10

Clinical pattern of corticosteroid dependent Crohn's disease.

Franchimont DP, Louis E, Croes F, Belaiche J. Franchimont DP, et al. Eur J Gastroenterol Hepatol. 1998 Oct;10(10):821-5. doi: 10.1097/00042737-199810000-00001. Eur J Gastroenterol Hepatol. 1998. PMID: 9831401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page